Heparin Market – Increasing incidences of coronary heart disease, pulmonary embolism, and deep vein thrombosis is expected to drive growth of market | Anselm Pharmaceuticals, Baxter International Inc

Overview:

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. It is used to prevent or treat certain blood vessel, heart, and lung conditions. Moreover, heparin is used to prevent blood clotting during open-heart surgery, bypass surgery, kidney dialysis, and blood transfusions, among others.

Click Here to Get a Sample Copy (Exclusive Offer: UPTO 30% Discount for A Limited Time) @ https://www.coherentmarketinsights.com/insight/request-sample/2602

Drivers:

Increasing prevalence of heart disease, venous thromboembolism, deep vein thrombosis, and pulmonary embolism and frequent approvals and launches of novel drugs are expected to boost the growth of the global heparin market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), each year, over one million in the U.S. die due to venous thromboembolism (VTE).

Moreover, in 2017, Portola Pharmaceuticals announced that the Food and Drug Administration (FDA) approved betrixaban (BEVYXXA) to treat adults with VTE. While, in December 2017, FDA approved use of Mylan NV’s heparin products. This includes Heparin Sodium Injection at 1000, 5000, 10,000, and 20,000 USP/mL, all of which are packaged in multi-dose vials.

Furthermore, in June 2018, Mylan launched Bivalirudin for Injection, 250 mg single-dose vial, in the United States. The product is indicated for use as an anticoagulant in patients.

Regional Insights:

Asia Pacific is expected to witness significant growth in the global heparin market due to the increase in demand for heparin in the region. For instance, China’s supplies of heparin to Hong Kong and Thailand increased sharply in 2016 to over 28,000 kgs and 40,000 kg, respectively, as per the Energy and Commerce Committee.

Competitive Landscape:

Major players active in the global heparin market are Baxter International Inc., Bristol-Myers Squibb Co., Anselm Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, LEO Pharma A/S, Leap Labchem Co., Pfizer, Inc., Syntex S.A., Sanofi S.A., United Biotech (P) Ltd., and Teva Pharmaceutical Industries Ltd., among others.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2602

The Study Objectives are:

✔ A comprehensive insight into key players operating in the Heparin Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Heparin Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Heparin Industry Impact

Chapter 2 Global Heparin Competition by Types, Applications, and Top Regions and Countries
2.1 Global Heparin (Volume and Value) by Type
2.3 Global Heparin (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Heparin Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Heparin Market Analysis
Chapter 6 East Asia Heparin Market Analysis
Chapter 7 Europe Heparin Market Analysis
Chapter 8 South Asia Heparin Market Analysis
Chapter 9 Southeast Asia Heparin Market Analysis
Chapter 10 Middle East Heparin Market Analysis
Chapter 11 Africa Heparin Market Analysis
Chapter 12 Oceania Heparin Market Analysis
Chapter 13 South America Heparin Market Analysis
Chapter 14 Company Profiles and Key Figures in Heparin Business
Chapter 15 Global Heparin Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology